We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$836B
AUM Growth
+$19.8B
Cap. Flow
-$11.8B
Cap. Flow %
-1.42%
Top 10 Hldgs %
35.57%
Holding
3,089
New
135
Increased
1,850
Reduced
836
Closed
113

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.01B
2
AVGO icon
Broadcom
AVGO
+$1.49B
3
GEV icon
GE Vernova
GEV
+$1.19B
4
IP icon
International Paper
IP
+$1.05B
5
SCHW
Charles Schwab
SCHW
+$952M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.31B
2
CEG icon
Constellation Energy
CEG
+$1.94B
3
QCOM icon
Qualcomm
QCOM
+$1.74B
4
NVDA icon
NVIDIA
NVDA
+$1.71B
5
CRM icon
Salesforce
CRM
+$1.5B

Sector Composition

Rank Sector Weight
1 Technology 33.98%
2 Healthcare 14.89%
3 Financials 10.35%
4 Consumer Discretionary 10.11%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKKT icon
2926
Bakkt Inc
BKKT
$336M
-655
Closed -$8K
BLND icon
2927
Blend Labs
BLND
$331M
$0 ﹤0.01%
+73,605
New +$195K
BLZE icon
2928
Backblaze
BLZE
$1.2B
$0 ﹤0.01%
+12,788
New +$99.7K
BN icon
2929
Brookfield
BN
$110B
-164,328
Closed -$4.59M
BUR icon
2930
Burford Capital
BUR
$962M
$0 ﹤0.01%
+63,669
New +$935K
BVS icon
2931
Bioventus
BVS
$1.17B
$0 ﹤0.01%
+12,041
New +$66.1K
BW icon
2932
Babcock & Wilcox
BW
$1.46B
-14,589
Closed -$17K
CATX icon
2933
Perspective Therapeutics
CATX
$372M
$0 ﹤0.01%
+15,019
New +$217K
CORZ icon
2934
Core Scientific
CORZ
$6.71B
$0 ﹤0.01%
+56,696
New +$290K
COWZ icon
2935
Pacer US Cash Cows 100 ETF
COWZ
$19.6B
-6,386
Closed -$372K
CTXR icon
2936
Citius Pharmaceuticals
CTXR
$21M
-1,209
Closed -$28K
DARE icon
2937
Dare Bioscience
DARE
$21.6M
-10,492
Closed -$62K
DEC
2938
Diversified Energy Company
DEC
$1.02B
$0 ﹤0.01%
+14,975
New +$208K
DHX icon
2939
DHI Group
DHX
$166M
-11,648
Closed -$30K
DSGR icon
2940
Distribution Solutions Group
DSGR
$1.61B
-9,417
Closed -$335K
EBS icon
2941
Emergent Biosolutions
EBS
$233M
-23,943
Closed -$61K
ECH icon
2942
iShares MSCI Chile ETF
ECH
$1.03B
-41,178
Closed -$1.09M
EFA icon
2943
iShares MSCI EAFE ETF
EFA
$80.2B
-211,128
Closed -$16.9M
ELEV
2944
DELISTED
Elevation Oncology
ELEV
$0 ﹤0.01%
+16,841
New +$63.4K
EOSE icon
2945
Eos Energy Enterprises
EOSE
$1.54B
-43,930
Closed -$46K
ERIC icon
2946
Ericsson
ERIC
$33.4B
-723,012
Closed -$3.98M
EWW icon
2947
iShares MSCI Mexico ETF
EWW
$1.9B
-16,938
Closed -$1.17M
EWZ icon
2948
iShares MSCI Brazil ETF
EWZ
$8.57B
-33,376
Closed -$1.08M
EXFY icon
2949
Expensify
EXFY
$202M
-17,284
Closed -$32K
HYPD
2950
Hyperion DeFi Inc
HYPD
$40.8M
-134
Closed -$11K

Similar funds

T. Rowe Price Associates's Q2 2024 Portfolio in Review

As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
  • T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
  • T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
  • T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
  • T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
  • T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
  • T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.

Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.